BXP vs TERN · rev $3.48B vs $6.12B cap
Boston Properties Inc (BXP) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
BXP currently screens at market cap $12.12B. TERN currently screens at market cap $6.12B.
Not investment advice. Open the BXP and TERN stock pages for the full models.
Not investment advice.